257 related articles for article (PubMed ID: 34044841)
1. Dynamic changes in peripheral blood lymphocyte subset counts and functions in patients with diffuse large B cell lymphoma during chemotherapy.
Hou H; Luo Y; Tang G; Zhang B; Ouyang R; Wang T; Huang M; Wu S; Li D; Wang F
Cancer Cell Int; 2021 May; 21(1):282. PubMed ID: 34044841
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Impact of Peripheral Blood T-Cell Subsets at the Time of Diagnosis on Survival in Patients with Diffuse Large B-Cell Lymphoma.
Shin HJ; Kim DY; Chung J; Shin KH; Lee H
Acta Haematol; 2021; 144(4):427-437. PubMed ID: 33271543
[TBL] [Abstract][Full Text] [Related]
3. [Expression and Clinical Significance of Cytokines and Lymphocyte Subsets in Patients with Diffuse Large B-Cell Lymphoma].
Xie Y; Bao HY; Shi XF; Wang JN; Han X; Meng QQ; Jiang SY; Zhang L; Zhang LB; Chen WR; Zou XD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Auguest; 31(4):1061-1068. PubMed ID: 37551478
[TBL] [Abstract][Full Text] [Related]
4. CD4(+) tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy.
Keane C; Gill D; Vari F; Cross D; Griffiths L; Gandhi M
Am J Hematol; 2013 Apr; 88(4):273-6. PubMed ID: 23460351
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood lymphocyte subsets of newly diagnosed DLBCL patients and their dynamic changes with rituximab based immunochemotherapy.
Yang Z; Yu W; Wang S; Zhou X; Liu S; Ma S
Leuk Lymphoma; 2019 Dec; 60(12):2909-2916. PubMed ID: 31120360
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and outcomes of patients with diffuse large B cell lymphoma treated with R-CHOP-like or CHOP-like regimens: an 8-year experience from a single center.
Huang H; Fan L; Fu D; Lin Q; Shen J
Ann Palliat Med; 2020 Jul; 9(4):1442-1452. PubMed ID: 32648457
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of circulating neutrophils and lymphocyte subsets in newly diagnosed patients with diffuse large B-cell lymphoma.
Yang Z; Yu W
Clin Exp Med; 2023 Jul; 23(3):815-822. PubMed ID: 35939174
[TBL] [Abstract][Full Text] [Related]
8. Ratios of T-cell immune effectors and checkpoint molecules as prognostic biomarkers in diffuse large B-cell lymphoma: a population-based study.
Keane C; Vari F; Hertzberg M; Cao KA; Green MR; Han E; Seymour JF; Hicks RJ; Gill D; Crooks P; Gould C; Jones K; Griffiths LR; Talaulikar D; Jain S; Tobin J; Gandhi MK
Lancet Haematol; 2015 Oct; 2(10):e445-55. PubMed ID: 26686046
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy.
Battella S; Cox MC; La Scaleia R; Di Napoli A; Di Landro F; Porzia A; Franchitti L; Mainiero F; Ruco L; Monarca B; Santoni A; Palmieri G
Cancer Immunol Immunother; 2017 Oct; 66(10):1295-1306. PubMed ID: 28555258
[TBL] [Abstract][Full Text] [Related]
10. The frequency of differentiated CD3
Worel N; Grabmeier-Pfistershammer K; Kratzer B; Schlager M; Tanzmann A; Rottal A; Körmöczi U; Porpaczy E; Staber PB; Skrabs C; Herkner H; Gudipati V; Huppa JB; Salzer B; Lehner M; Saxenhuber N; Friedberg E; Wohlfarth P; Hopfinger G; Rabitsch W; Simonitsch-Klupp I; Jäger U; Pickl WF
Front Immunol; 2022; 13():1004703. PubMed ID: 36700229
[TBL] [Abstract][Full Text] [Related]
11. Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Marcheselli R; Bari A; Tadmor T; Marcheselli L; Cox MC; Papotti R; Ferrari A; Baldini L; Gobbi P; Levy I; Pugliese G; Federico M; Polliack A; Pozzi S; Sacchi S
Hematol Oncol; 2020 Oct; 38(4):439-445. PubMed ID: 32495944
[TBL] [Abstract][Full Text] [Related]
12. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma.
Plonquet A; Haioun C; Jais JP; Debard AL; Salles G; Bene MC; Feugier P; Rabian C; Casasnovas O; Labalette M; Kuhlein E; Farcet JP; Emile JF; Gisselbrecht C; Delfau-Larue MH;
Ann Oncol; 2007 Jul; 18(7):1209-15. PubMed ID: 17496307
[TBL] [Abstract][Full Text] [Related]
13. Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapy.
Yin Q; Chen L; Li Q; Mi R; Li Y; Wei X; Song Y
Cancer Cell Int; 2014; 14():85. PubMed ID: 25705124
[TBL] [Abstract][Full Text] [Related]
14. Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma.
Xu-Monette ZY; Li L; Byrd JC; Jabbar KJ; Manyam GC; Maria de Winde C; van den Brand M; Tzankov A; Visco C; Wang J; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Parsons BM; Winter JN; Wang M; Hagemeister FB; Piris MA; Han van Krieken J; Medeiros LJ; Li Y; van Spriel AB; Young KH
Blood; 2016 Dec; 128(26):3083-3100. PubMed ID: 27760757
[TBL] [Abstract][Full Text] [Related]
15. Soluble MIC-A, IPI, and response to treatment strongly predict survival in patients with germinal center diffuse large B cell lymphoma.
Vela-Ojeda J; Olivas-Bejarano AC; Montiel-Cervantes LA; Rosales-Cruz E; Garcia-Gutierrez S; Lezama-Palacios RA; Reyes-Maldonado E
Eur J Haematol; 2024 May; ():. PubMed ID: 38742655
[TBL] [Abstract][Full Text] [Related]
16. The gut microbiota correlate with the disease characteristics and immune status of patients with untreated diffuse large B-cell lymphoma.
Lin Z; Mao D; Jin C; Wang J; Lai Y; Zhang Y; Zhou M; Ge Q; Zhang P; Sun Y; Xu K; Wang Y; Zhu H; Lai B; Wu H; Mu Q; Ouyang G; Sheng L
Front Immunol; 2023; 14():1105293. PubMed ID: 36891300
[TBL] [Abstract][Full Text] [Related]
17. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
18. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
Xie J; Wang HL; Qiu ZF; Li TS
Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
[TBL] [Abstract][Full Text] [Related]
19. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
20. [The prognostic value of the international prognostic index, the national comprehensive cancer network IPI and the age-adjusted IPI in diffuse large B cell lymphoma].
Song JL; Wei XL; Zhang YK; Hao XX; Huang WM; Wei Q; Wei YQ; Feng R
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):739-744. PubMed ID: 30369184
[No Abstract] [Full Text] [Related]
[Next] [New Search]
